Pfizer Says Three Shots Of Low-Dose Vaccine Generates ‘Strong Immune Response’ In Kids Under 5

Pfizer and BioNTech said they will finish submitting data to the FDA “this week” as they seek authorization for the shots, which aren’t yet available to children under 5.

Source: Forbes.com Healthcare News - May 23, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Science /science Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news